Introduction
============

Asthma is a prevalent chronic pulmonary disease in the childhood. It is usually characterized by chronic airway inflammation that results in a decreased aerobic capacity, and its prevalence is increasing in many countries ([@B9]).

Cardiorespiratory fitness is considered an important marker of health in youth, since high cardiorespiratory fitness in youth have shown to track do adult ages ([@B11]). In addition, children with higher cardiorespiratory fitness present lower prevalence of cardiovascular risk factors including obesity and high blood pressure ([@B5]; [@B8]). Therefore, assessment of cardiorespiratory fitness can provide valuable information regarding health status in pediatric populations.

The measurement of maximal peak oxygen uptake (V[O]{.smallcaps}~2max~) have been considered the gold standard for cardiorespiratory fitness assessment ([@B2]). However, due to its cost and time to assessment, field tests, such as incremental shuttle-walk test, have been proposed to assess cardiorespiratory fitness in clinical settings ([@B25]). In patients with asthma, a previous study analyzed the validity of shuttle-run test ([@B1]), a progressive externally-paced field test, to predict VO~2peak~ in adolescents with asthma, and observed that the shuttle-run test has sufficient validity to assess oxygen uptake. However, the severer asthmatic patients could not perform the shuttle-run because there is a high speed increasing.

In this context, field tests that includes walking, such as shuttle-walk test ([@B24]) or modified shuttle-walk test ([@B7]) (MST), have been proposed for patients with pulmonary diseases. The studies have observed significant correlations between the performance in incremental shuttle-walk test and VO~2peak~, in adults with various chronic conditions, including asthma ([@B19]; [@B18]). However, whether similar relationships occur in children or adolescents with asthma is unknown. Thus, the aims of the current study were (1) to evaluate the relationship between MST and VO~2peak~ in children and adolescents with asthma, and (2) to develop and validate an equation to predict VO~2peak~ based on MST test.

Materials and Methods {#s1}
=====================

Patients
--------

Patients between 6 and 18 years of age were recruited in 2013 through 2015 from the Pediatric Department of the Federal University of São Paulo, Brazil. All patients had been diagnosed by a pediatric physician, according to the GINA steps ([@B9]), as having asthma for at least 6 months, and had been on a stable treatment regime for at least 3 months. Patients were excluded from this study when no regular medication regime was being followed, if any exacerbation had occurred in the last 4 weeks before inclusion, or if the patient was not able to perform any of the tests needed for this study.

Patients were divided into two groups: (1) the equation group (EG), which included patients who were studied to construct the equation model of VO~2peak~, and (2) a cross-validation group (VG), which included patients for preliminary validation of the equation model. Patients were included in the study after their legal guardians read, agreed to, and signed the informed consent form, and the patient had signed the informed consent if they were 12 years of age or older. The study was approved by the Associaçao Educacional Nove de Julho Ethical Committee, São Paulo, Brazil (\#738192/2014).

Study Design and Protocol
-------------------------

This is a cross sectional study. All outcome measurements needed for this study were taken on two different days. The outcome measurements that were assessed included an asthma control questionnaire, lung function spirometry (pre- and post-bronchodilator), the MST and the cardiopulmonary exercise test (CPET). The MST and CPET were performed on different days, in random order.

Asthma Control Questionnaire
----------------------------

The asthma control test (ACT) is a simple questionnaire to assess asthma control based on patient views, used for patients over 12 years old. The children's ACT (C-ACT) is used for children 4 through 11 years old ([@B16]). Each question is answered on a scale of 1 (worst) to 5 (best). The highest total score for ACT is 25, and for C-ACT is 27. Asthma is considered controlled when the score is 20 or over. A score of 16 to 19 is considered partially-controlled asthma, and 15 or under is uncontrolled asthma ([@B16]).

Lung Function
-------------

Spirometry was performed with ULTIMA CPX equipment (MGC Diagnostics Corporation. Saint Paul, MN, United States). The technical procedure, acceptance criteria and reproducibility were according to ATS/ERS statement ([@B27]). The patients repeated the test after use of a bronchodilator (salbutamol, 400 μg). The forced vital capacity (FVC), expiratory forced volume at the first second (FEV~1~), FEV~1~/FVC, and forced expiratory flow at 25 to 75% of FVC (FEF~25-75~) were expressed in liters and percentage of predict value ([@B20]), and z-score based on the mean value.

Modified Shuttle Test
---------------------

The modified shuttle test (MST) was performed in a 10-m-long corridor according to the previous description ([@B7]). It is an externally-paced test dictated by an audio signal. The test has 15 levels, in which the speed increases every minute, ranging from 1.8 to 10.2 km/h, and requires the patient to walk/run at the increasing speed. The test was halted if the patient was not able to reach the distance two consecutive times, if he/she needed to stop due to fatigue or breathlessness, or if SpO~2~ fell below 82% ([@B25]). Each patient performed the test twice on the same day, with a 30-min rest in between. Heart rate, measured with a Polar FT70^®^ monitor, and SpO~2~, measured with a handheld oximeter (920M, Philips^®^, United States) were continuously evaluated. The modified Borg scale was used to observe lower limb fatigue and dyspnea at the beginning and end of the test ([@B6]). The greatest DW for the two MST, expressed in meters and as a percentage of predicted value ([@B13]), was used for analysis as an outcome.

Cardiopulmonary Exercise Test
-----------------------------

The CPET was performed to identify if MST was maximal test. The cycle ergometer (Corival^®^, LODE BV Medical Technology, Groningen, Netherlands) was used. After 2 min of unloaded cycling, the load was increased (10 to 20 watts/minute) ([@B10]), and the test was aimed to last between 8 and 12 min ([@B2]). The heart rate and SpO~2~ were continuously recorded. Blood pressure was measured every 2 min during the test. Modified Borg dyspnea and Modified Borg lower limb were assessed at beginning and the end of the test. The primary outcome of CPET was the VO~2peak~.

All patients performed the MST and CPET while connected to a validated ([@B12]) system for gas exchange analyses (VO~2000~, MedGraphics Corporation^®^, Saint Paul, MN, United States). The VO~2~, pulmonary dioxide production (VCO~2~), the relationship between them (RER: VCO~2~/VO~2~), and minute ventilation (VE) were continuously measured.

Statistical Analysis
--------------------

The Shapiro--Wilk test was used to determine the normality of the data. The variables were described by mean ± SD or median (IQ 25 to 75%), according to the normality of the data. The paired *t*-student test was used to compare the characteristics between CPET and MST. The unpaired Student's *t*-test or Mann--Whitney *U*-test was used to compare the characteristics of CPET and MST between EG and VG groups. The Pearson's coefficient of correlation was performed to study the correlation between VO~2peak~ and age, height, weight, and distance walked. Subsequently, the multiple backward linear regression analysis was performed to identify predictors of the dependent variable (VO~2peak~) measured during MST. Age, height, weight, sex, and distance walked during MST were tested as independent variables. To validate the equation, the measured VO~2peak~ of the VG patients was compared to the predicted VO~2peak~. The intraclass correlation coefficient (ICC) and its 95% confidence interval (CI) were calculated using an absolute agreement definition, to evaluate the relative reliability between VO~2peak~ measured and predicted. The agreement between VO~2peak~ measured and predicted was assessed by Bland--Altman analysis. A sample size of at least 15 patients per variable was used in the final equation model developed using linear regression. The *post hoc* power of the validation group was calculated.

SPSS version 20 (Chicago, IL, United States) statistical software was used in the study. A *p*-value less than 0.05 was considered statistically significant.

Results
=======

A total of 153 children and adolescents with asthma were invited to participate, of which 97 were included (34 did not sign the informed consent form, 17 had asthma exacerbation occurring in the past 4 weeks, and five failed to follow the test procedure). Assuming a ratio 2:1, a total of 68 patients were randomly included in the equation group (56% boys). Another 29 VG patients (61% boys) were evaluated to validate the equation. They also had normal lung function and a median GINA step of 3 (2 to 4), **Table [1](#T1){ref-type="table"}**.

###### 

Anthropometric characteristics and lung function of the studied groups.

  Variables                Equation group *N* = 68   Validation group *N* = 29   *p*
  ------------------------ ------------------------- --------------------------- ------
  Age (years)              10.5 ± 3.2                10.8 ± 3.1                  0.51
  Weight (kg)              42.7 ± 15.7               40.5 ± 15.8                 0.70
  Height (cm)              143.0 ± 17.2              142.4 ± 14.7                0.73
  FVC, L (%)               2.6 ± 0.8 (104 ± 12)      2.4 ± 0.8 (100 ± 13         0.33
  FVC z-score^∗^           0.0 (-0.8 to 0.5)         0.0 (-0.5 to 0.3)           0.78
  FEV~1~, L (%)            2.2 ± 0.7 (100 ± 14)      2.0 ± 0.6 (93 ± 15)         0.12
  FEV~1~ z-score^∗^        -0.1 (-0.6 to 0.6)        -0.1 (-0.7 to 0.8)          0.93
  FEV~1~/FVC               88 ± 6                    85 ± 9                      0.33
  FEV~1~/FVC z-score^∗^    0.2 (-0.6 to 0.7)         0.2 (-0.8 to 0.7)           0.95
  FEF~25-75~, L (%)        2.9 ± 1.1 (114 ± 35)      2.4 ± 1.0 (103 ± 35)        0.22
  FEF~25-75~ z-score^∗^    -0.1 (-0.8 to 0.8)        -0.1 (-0.7 to 0.3)          0.72
  Asthma control test^∗^   21 (18 to 23)             20 (18 to 22)               0.44
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∗

median (IQ 25--75%).

Of 84 (86%) of 97 patients performed the CPET according to the recommendations. The variables of CPET and MST were compared to be sure that a field test (the MST) had similar responses to the gold standard test. They had a significantly higher VO~2peak~ at MST (1.9 ± 0.6 L/min) than they did at CPET (1.5 ± 0.4 L/min), *p* \< 0.001. A similar result was observed for their heart rate (MST: 186 ± 13 bpm vs. CPET: 178 ± 11 bpm; *p* \< 0.001), but not statically difference for RER~peak~ between tests (MST: 1.1 ± 0.1 vs. CPET: 1.1 ± 0.1; *p* = 0.29).

All patients stopped the MST at maximal effort (leg fatigue or breathlessness reported on the Borg scale, or incapacity to follow the test speed). There was a significant association between VO~2peak~, distance walked, age, weight, and height (*r* \> 0.7; *p* \< 0.05) for the EG (**Figure [1](#F1){ref-type="fig"}**). The final model of the linear multiple regression analysis included gender, weight, and distance walked during MST. The standardized coefficient β is shown in **Table [2](#T2){ref-type="table"}**.

###### 

Predicted variables for peak oxygen uptake, VO~2peak~ in L/min, based on the modified shuttle test obtained from multiple linear regression analysis.

  Variables             Unstandardized coefficients β   Standardized coefficients β   *p*
  --------------------- ------------------------------- ----------------------------- ---------
  Constant              -0.457                                                        
  Gender                0.139                           0.103                         \<0.001
  Weight (kg)           0.025                           0.585                         \<0.001
  Distance walked (m)   0.002                           0.527                         \<0.001
                                                                                      

Gender: boys = 1; girls = 0.

![Association between VO~2peak~, distance walked, age, weight, and height for the equation group.](fphys-09-00919-g001){#F1}
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1.  Adjusted R^2^: 0.87; SEE: 0.24;

2.  Gender: boys = 1; girls = 0;

3.  Weight: kg;

4.  DW: distance walked at MST, in meters.

There was no difference between the equation and validations groups in the variables at the peak of MST (**Table [3](#T3){ref-type="table"}**). No adverse events were reported during or after the MST. The VO~2peak~ measured during the MST of the validation group (1.9 ± 0.5 L/min) was not different of the VO~2peak~ predicted by the equation (2.0 ± 0.5 L/min), *p* = 0.67 (**Figure [2](#F2){ref-type="fig"}**). The *post hoc* power between the VO~2peak~ measured and predicted was 83%.

###### 

Variables at the peak of the modified shuttle test in both groups.

  Variables               Equation group *N* = 68   Validation group *N* = 29   *p*
  ----------------------- ------------------------- --------------------------- ------
  DW, m (%pred)           760 ± 209 (80 ± 14)       731 ± 180 (77 ± 15)         0.51
  HR~peak~, bpm (%pred)   185 ± 14 (92 ± 8)         187 ± 11 (93 ± 6)           0.51
  VO~2peak~, L/min        1.9 ± 0.6                 1.9 ± 0.5                   0.92
  VCO~2peak~, L/min       2.0 ± 0.8                 2.0 ± 0.7                   0.94
  RER~peak~               1.0 ± 0.1                 1.0 ± 0.1                   0.86
  VE~peak~, L/min         45.4 ± 14.5               47.0 ± 16.4                 0.66
  VE/VO~2peak~            23.6 ± 3.0                23.8 ± 2.2                  0.82
  VE/VCO~2peak~           22.9 ± 3.2                23.2 ± 2.8                  0.73
  SpO~2peak~, %           90 ± 5                    91 ± 5                      0.60
  Desaturation, %^∗^      -6 (-10 to -2)            -5 (-10 to -2)              0.98
  Borg dyspnea^∗^         4 (3 to 5.5)              3 (3 to 5)                  0.57
  Borg lower limb^∗^      4 (3 to 6)                3.5 (2 to 6)                0.67
                                                                                

DW, distance walked at MST; HR, heart rate; VO
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median (IQ 25--75%).

![Comparison between VO~2peak~ measured and VO~2peak~ predicted, *p* = 0.67.](fphys-09-00919-g002){#F2}

The ICC of the VO~2peak~ measured and predicted in the validation group was highly significant (ICC: 0.91, CI95% 0.77 to 0.96; *p* \< 0.001). The Bland--Altman analysis showed a mean bias of -0.15 L/min, with the limits of agreement ranging from -0.65 to 0.35 L/min.

Discussion
==========

The main results of the present study were: (i) gender, weight, and DW during MST explained 87% of the variance in VO~2peak~; (ii) There was no difference between the equation and validations groups in the variables at the peak of MST; (iii) The ICC of the VO~2peak~ measured and predicted in the validation group was highly significant; (iv) MST elicited higher peak VO~2~ and heart rate than CPET.

It was observed highest VO~2peak~ and heart rate during MST compared to the CPET. This result occurred because the CPET was performed on a cycle ergometer and MST is a walk/run test. The CPET is considered a gold standard assessment for exercise capacity, regardless of whether it is performed on a treadmill or a cycle ergometer ([@B2]), but it is known that VO~2peak~ is higher on a treadmill ([@B17]).

As expected weight and gender were included in the VO~2peak~ prediction equation. It is known that the absolute peak oxygen uptake is related to a child's growth ([@B26]). Usually, the VO~2peak~ is 20% higher in children than in adults ([@B29]). This is because children have higher capillary and mitochondrial density, and oxidative enzyme activity than do adults ([@B29]; [@B22]; [@B3]). Gender also influences the VO~2peak~ ([@B22]). Girls have usually lower VO~2peak~ levels compared to boys, at least for the onset of puberty ([@B4]). Oxygen uptake is related to the stroke volume of the heart, which is greater in boys, justifying the gender differences ([@B30]). Additionally, boys have a higher percentage of free-fat mass (especially after puberty) compared to girls, which further increases their oxygen uptake during maximal exercise ([@B22]; [@B26]).

In same way, the distance walked was included in the final model of VO~2peak~ equation. Because of the incremental increase of the walking speed every minute of MST, the distance walked is related to the intensity of the exercise, and hence, the oxygen uptake. This is in agreement with previous studies in adults ([@B15]; [@B14]; [@B28]; [@B21]) that also included the distance walked to predict VO~2peak~. However, in these studies this variable explained less than 50% of the VO~2peak~, while in the current study DW, gender and weight explained 87%. This can be justified because these independent variables are proportional related to the oxygen uptake.

This is the first study to determine an equation for prediction of VO~2peak~ based on the MST in children and adolescents with asthma. The results in the cross-validation asthmatic patients revealed a high correlation between the predicted and obtained VO~2peak~, with small bias between them -0.15 L/min. In addition, although there was a wide limit of agreement, greater than 0.5 L/min (∼25% of VO~2peak~), it is similar to the results of [@B1] who observed similar variability (∼25% of VO~2peak~) between VO~2peak~ measured and predicted in a study of patients with adolescents with asthma.

In practical terms, our proposed equation to estimate VO~2peak~ in children and adolescents from 6 to 18 years with asthma presented psychometric characteristics similar than other equations in adolescent and adult patients with asthma. The MST seems to be an appropriate test to evaluate pediatric patients, because it is performed at a wide range of speeds, and this avoids floor or ceiling effects ([@B23]).

The limitation of this study includes the small number of patients with severe asthma (GINA step 5), which reduced the external validity for the equation in this subgroup of patients. The CPET was not properly performed in all participants, but more than 80% of them performed it. There was not included a control group of healthy participants, and whether differences exist between healthy and asthmatic youth cannot be determined. However, considering that equations for this specific group was not available until now, the inclusion of only asthmatic still relevant to determine an equation for pulmonary chronic conditions.

Conclusion
==========

The developed equation indicated high correlation and low bias in the prediction VO~2peak~ based in the MST in pediatric patients with asthma. Therefore, this test can be a useful alternative to assess VO~2peak~ in clinical settings.
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